Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?

Summary:The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operations and greater access for patients. More specifically, this panel focuses on: What is the true value of site networks?What does the landscape look like today – by TA/country / region?If scaled, what will the benefit look like for patients and can it impact the speed of treatment to patients?Case examples of the impact of current clinical research networksIn this panel:Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, MerckPaul Evans, President and CEO, Velocity Clinical ResearchMark Scullion, MBA, CEO, Atlas Clinical ResearchNick Slack, MBE, Chairman and CEO, The START Center for Cancer ResearchFor more information, go to DPHARMconference.com.